INVA Competitors & Alternatives
Compare Innoviva Inc with similar stocks in the same industry
Biotechnology
INVA
Main Stock$20.66
Tradestie Score
47
Market Cap
$1.15B
P/E Ratio
4.9
Revenue Growth
0.2%
Analyst Upside
+69.4%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BHVN
Biohaven Ltd.
|
$13.88
|
$1.57B | - | 40 | Compare |
|
VCEL
Vericel Corporation
|
$42.53
|
$1.56B | 91.4 | 53 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$76.78
|
$1.55B | - | 52 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$36.13
|
$1.55B | 11.6 | 59 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$31.41
|
$1.55B | - | 55 | Compare |
|
NVAX
Novavax Inc
|
$9.70
|
$1.54B | - | 44 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.86
|
$1.50B | 7.6 | 49 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$21.19
|
$1.50B | - | 50 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$27.20
|
$1.49B | - | 54 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$18.54
|
$1.43B | - | 42 | Compare |
More INVA Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry